medigraphic.com
ISSN 2683-1678 (Impreso)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2018, Número 1

<< Anterior Siguiente >>

Rev Latin Infect Pediatr 2018; 31 (1)


Impacto de las enfermedades diarreicas agudas en América Latina Justificación del establecimiento de un Comité de Enfermedades Diarreicas en SLIPE

Herrera-Benavente IF, Comas-García A, Mascareñas-de los Santos AH

Idioma: Español
Referencias bibliográficas: 62
Paginas: 8-16
Archivo PDF: 252.26 Kb.


RESUMEN

Las enfermedades diarreicas agudas (EDA) son una de las principales causas de morbilidad y mortalidad a nivel mundial, particularmente en el grupo de niños menores de cinco años. A pesar de que los programas de control de las EDA han logrado disminuir el impacto de estas infecciones en las últimas tres décadas, dicha reducción no ha sido homogénea en los países que conforman Latinoamérica. La heterogeneidad en los resultados se debe a la amplia diversidad política, económica, social, cultural y de salud. Por lo tanto, en la Sociedad Latinoamericana de Infectología Pediátrica (SLIPE) consideramos que es necesario contar con un Comité de Enfermedades Diarreicas (CED), que deberá ser un eje fundamental en el desarrollo de acciones de promoción y prevención de las EDA. El CED deberá desarrollar documentos y consensos que señalen las estrategias y líneas de acción claras que coadyuven al fortalecimiento en el manejo y prevención de las EDA.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Global Burden of Diarrhoeal Diseases Collaborators. Estimates of global, regional, national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017; 17 (9): 909-948.

  2. Fischer WC, Aryee MJ, Boschi PC, Black RE. Estimating diarrhea mortality among young children in low and middle income countries. PLoS ONE. 2012; 7 (1): e29151.

  3. Fischer WC, Perin J, Aryee MJ, Boschi-Pinto C, Black RE. Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health. 2012; 12: 220.

  4. Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998; 279 (17): 1371-1376.

  5. Snyder JD, Merson MH. The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull World Health Organ. 1982; 60 (4): 605-613.

  6. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ. 1992; 70 (6): 705-714.

  7. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003; 81 (3): 197-204.

  8. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet. 2005; 365 (9465): 1147-1152.

  9. Boschi-Pinto C, Velebit L, Shibuya K. Estimating child mortality due to diarrhoea in developing countries. Bull World Health Organ. 2008; 86 (9): 710-717.

  10. You D, Wardlaw T, Salama P, Jones G. Levels and trends in under-5 mortality, 1990-2008. Lancet. 2010; 375 (9709): 100-103.

  11. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010; 375 (9730): 1969-1987.

  12. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379 (9832): 2151-2161.

  13. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2095-2128.

  14. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA et al. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013; 381 (9875): 1405-1416.

  15. World Health Organization. The treatment and prevention of acute diarrhoea. Practical guidelines. First ed. Geneva: WHO; 1985.

  16. World Health Organization. The treatment and prevention of acute diarrhoea. Practical guidelines. Second ed. Geneva: WHO; 1989.

  17. World Health Organization. The treatment and prevention of acute diarrhoea. Practical guidelines. Third ed. Geneva: WHO; 1993.

  18. World Health Organization – Department of Child and Adolescent Health and Development. The Treatment of Diarrhoea. A Manual for physicians and other senior health workers, Fourth ed. Geneva: WHO; 2005.

  19. Ganguly E, Sharma PK, Bunker CH. Prevalence and risk factors of diarrhea morbidity among under five children in India: a systematic review and meta-analysis. Indian J Child Health (Bhopal). 2015; 2 (4): 152-160.

  20. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013; 382 (9888): 209-222.

  21. Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016; 388 (10051): 1291-1301.

  22. Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health. 2015; 3 (9): e564-575.

  23. Liu J, Kabir F, Manneh J, Lertsethtakarn P, Begum S, Gratz J et al. Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study. Lancet Infect Dis. 2014; 14 (8): 716-724.

  24. Platts-Mills JA, Liu J, Houpt ER. New concepts in diagnostics for infectious diarrhea. Mucosal Immunol. 2013; 6 (5): 876-885.

  25. Smieja M, Goldfarb DM. Molecular detection of diarrheal pathogens. Clin Microbiol Newslett. 2016; 38 (17): 137-145.

  26. Binnicker MJ. Multiplex molecular panels for the diagnosis of gastrointestinal infection: performance, result interpretation and cost effectiveness. J Clin Microbiol. 2015; 53 (12): 3723-3728.

  27. Levine MM, Kotloff KL, Nataro JP, Muhsen K. The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis. Clin Infect Dis. 2012; 55 (Suppl. 4): S215-S224.

  28. Keusch GT, Walker CF, Das JK, Horton S, Habte D. Chapter 9. In: Black RE, Laxminarayan R, Temmerman M, Walker N, editors. Disease Control Priorities (third edition). Volume 2. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2016.

  29. Ruxin JN. Magic bullet: the history of oral rehydration therapy. Med Hist. 1994; 38 (4): 363-397.

  30. Tickell KD, Walson JL. Nutritional enteric failure: neglected tropical diseases and childhood stunting. PLoS Negl Trop Dis. 2016; 10 (4): e0004523.

  31. Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2016; 12: CD005436.

  32. World Health Organization/UNICEF. Joint statement: clinical management acute diarrhoea (WHO/FCH/CAH/04.07). Geneva and New York: World Health Organization, Department of Child and Adolescent Health and Development, and United Nations Children’s Fund, Programme Division, 2004.

  33. WHO. The treatment of diarrhoea: a manual for physicians and other senior health workers. Geneva: World Health Organization, 2005.

  34. Applegate JA, Fisher WC, Ambikapathi R, Black RE. Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children. BMC Public Health. 2013; 13 (Suppl. 3): S16.

  35. Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014; 59 (1): 132-152.

  36. Pop M, Walker AW, Paulson J, Lindsay B, Antonio M, Hossain MA et al. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol. 2014; 15 (6): R76.

  37. Basu S, Paul DK, Ganguly S, Chatterjee M, Chandra PK. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhoea of Indian children: a randomised controlled trial. J Clin Gastroenterol. 2009; 43 (3): 208-213.

  38. Basu S, Chatterjee M, Ganguly S, Chandra PK. Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: a randomized controlled trial. J Paediatr Child Health. 2007; 43 (12): 837-842.

  39. Aggarwal S, Upadhyay A, Shah D, Teotia N, Agarwal A, Jaiswal V. Lactobacillus GG for treatment of acute childhood diarrhoea: open labelled, randomized controlled trial. Indian J Med Res. 2014; 139 (3): 379-385.

  40. Misra S, Sabui TK, Pal NK. A randomized controlled trial to evaluate the efficacy of Lactobacillus GG in infantile diarrhea. J Pediatr. 2009; 155 (1): 129-132.

  41. Dutta P, Mitra U, Dutta S, Rajendran K, Saha TK, Chatterjee MK. Randomised controlled clinical trial of Lactobacillus sporogenes (Bacillus coagulans), used as probiotic in clinical practice, on acute watery diarrhoea in children. Trop Med Int Health. 2011; 16 (5): 555-561.

  42. Khanna V, Alam S, Malik A, Malik A. Efficacy of tyndalized Lactobacillus acidophilus in acute diarrhea. Indian J Pediatr. 2005; 72 (11): 935-938.

  43. Hegar B, Waspada IM, Gunardi H, Vandenplas Y. Double blind randomized trial showing probiotics to be ineffective in acute diarrhea in Indonesian children. Indian J Pediatr. 2015; 82 (5): 410-414.

  44. Riaz M, Alam S, Malik A, Ali SM. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised controlled trial. Indian J Pediatr. 2012; 79 (4): 478-482.

  45. Corrêa NB, Penna FJ, Lima FM, Nicoli JR, Filho LA. Treatment of acute diarrhea with Saccharomyces boulardii in infants. J Pediatr Gastroenterol Nutr. 2011; 53 (5): 497-501.

  46. Grandy G, Medina M, Soria R, Terán CG, Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis. 2010; 10: 253.

  47. Panigrahi P, Parida S, Nanda NC, Satpathy R, Pradhan L, Chandel DS et al. A randomized symbiotic trial to prevent sepsis among infants in rural India. Nature. 2017; 548 (7668): 407-412.

  48. Freedman SB, Ali S, Oleszczuk M, Gouin S, Hartling L. Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries. Evid Based Child Health. 2013; 8 (4): 1123-1137.

  49. Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S et al. Treatment of travelers’ diarrhea: randomized trial comparing rifaximin, rifaximina plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol. 2007; 5 (4): 451-456.

  50. Li ST, Grossman DC, Cummings P. Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Med. 2007; 4 (3): e98.

  51. Gharial J, Laving A, Were F. Racecadotril for the treatment of severe acute watery diarrhoea in children admitted to a tertiary hospital in Kenya. BMJ Open Gastroenterol. 2017; 4 (1): e000124.

  52. Kang G, Thuppal SV, Srinivasan R, Sarkar R, Subashini B, Venugopal S et al. Racecadotril in the management of rotavirus and non-rotavirus diarrhea in under-five children: two randomized, double-blind, placebo-controlled trials. Indian Pediatr. 2016; 53 (7): 595-600.

  53. Gordon M, Akobeng A. Racecadotril for acute diarrhoea in children: systematic review and meta-analyses. Arch Dis Child. 2016; 101 (3): 234-240.

  54. Pérez-Gaxiola G, Cuello-García CA, Florez ID, Pérez-Pico VM. Smectite for acute infectious diarrhoea in children. Cochrane Database Syst Rev. 2018; 4: CD011526.

  55. Gutiérrez-Castrellón P, Ortiz-Hernández AA, Llamosas-Gallardo B, Acosta-Bastidas MA, Jiménez-Gutiérrez C, Díaz-García L et al. Efficacy of racecadotril vs. smectite, probiotics or zinc as an integral part of treatment of acute diarrhea in children under five years: A meta-analysis of multiple treatments. Gac Med Mex. 2015; 151 (3): 329-337.

  56. Black R. Would control of childhood infectious diseases reduce malnutrition? Acta Paediatr Scand Suppl. 1991; 374: 133-140.

  57. Checkley W, Epstein LD, Gilman R, Cabrera L, Black RE. Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidemiol. 2003; 157 (2): 166-175.

  58. Niehaus M, Moore S, Patrick P, Derr LL, Lorntz B, Lima AA et al. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg. 2002; 66 (5): 590-593.

  59. Scharf RJ, Deboer MD, Guerrant RL. Recent advances in understanding the long-term sequelae of childhood infectious diarrhea. Curr Infect Dis Rep. 2014; 16 (6): 408.

  60. Thapar N, Sanderson IR. Diarrhea in children: an interface between developing and developed countries. Lancet. 2004; 363 (9409): 641-653.

  61. Fischer WC, Friberg IK, Binkin N, Young M, Walker N, Fontaine O et al. Scaling up diarrhea prevention and treatment interventions: a Lives Saved Tool analysis. PloS Med. 2011; 8 (3): e1000428.

  62. Petri WA, Miller M Jr, Binder HJ, Levine MM, Dillingham R, Guerrant RL. Enteric infections, diarrhea, and their impact on function and development. J Clin Invest. 2008; 118 (4): 1277-1290.




2020     |     www.medigraphic.com